"Dot-17 alpha-hydroxyprogesterone" radioimmunoassay for identification of congenital adrenal hyperplasia in young infants. 1981

J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy

Using a simplified radioimmunoassay method for the determination of 17-hydroxyprogesterone (17-OHP) concentration in blood dried on filter paper seven untreated cases of congenital adrenal hyperplasia were identified among newborns and infants at risk for congenital adrenal hyperplasia (CAH) having ambiguous genitalia and/or failure to thrive with electrolyte disturbances. In three additional cases the diagnosis of congenital adrenal hyperplasia was confirmed by high 'dot-17-OHP' values even after glucocorticoid therapy had been started. Capillary blood samples taken in a local hospital on a filter paper routinely used for the screening of phenylketonuria can be sent by mail into a central laboratory for performing the analysis. Assays of 'dot-17-OHP' are clearly of diagnostic value in the C21-hydroxylase form of CAH and permit a rapid diagnosis of this condition in the newborn period.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006908 Hydroxyprogesterones Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
December 1979, Clinical endocrinology,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
March 1985, Clinical chemistry,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
January 1987, Annals of clinical biochemistry,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
June 1981, Clinical endocrinology,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
January 1980, Horumon to rinsho. Clinical endocrinology,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
November 1977, The Journal of clinical endocrinology and metabolism,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
April 1979, Clinical chemistry,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
March 1984, Lancet (London, England),
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
January 1989, Medicinski pregled,
J Sólyom, and S Hervei, and P Marossy, and E Sólyom, and M Babosa, and G Szombathy
January 1956, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
Copied contents to your clipboard!